PS-341
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for PS-341, covering 2011-02-24 to 2018-10-31. Get the full timeline:
Most recent: Clinical Trial Update: Proteasome Inhibitor PS-341 Relapsed or Refractory B Cell Lymphomas Previously Treated With Chemotherapy [Phase 2]